# FDA Inspection 571860 - AstraZeneca, PLC - March 26, 2009

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-plc/f4d97914-e3eb-483d-bd0c-48f0d35e9740
Source feed: FDA_Inspections

> FDA Inspection 571860 for AstraZeneca, PLC on March 26, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 571860
- Company Name: AstraZeneca, PLC
- Inspection Date: 2009-03-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 922364 - 2015-03-20](https://www.keypedia.com/records/fda_inspections/astrazeneca-plc/82c5acc8-90a6-463e-9781-292cec32db92)
- [FDA Inspection 824640 - 2013-03-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-plc/526b22c3-a997-448f-9730-c455b69fbe55)
- [FDA Inspection 824640 - 2013-03-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-plc/c39969ff-f65b-426d-a7ab-33c1940967a9)
- [FDA Inspection 759884 - 2011-12-21](https://www.keypedia.com/records/fda_inspections/astrazeneca-plc/a9767e55-ab96-4dcf-9919-ebb4e978ab57)
- [FDA Inspection 680556 - 2010-08-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-plc/6e431ac1-24ee-4b38-9a4c-27e0d1a7c8ca)

Company: https://www.keypedia.com/companies/astrazeneca-plc/6293ea11-7657-47b7-8ae6-b97f9afcae84

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c